Upcoming Events:

Washington Division - HRO - Healthcare Summit

Saturday, March 16, 2024 | 9:00 AM - 11:30 AM (EST) | In person and Virtual

The Drug Enforcement Administration, Washington Division will be hosting a series of Healthcare Summits to present an overview of the federal regulations regarding Controlled Substances (CS) and the responsibilities of DEA Registrants under the Controlled Substances Act (CSA) to ensure the proper handling of CS, and the identification and prevention of diversion activity stemming from various sources. The inaugural Summit will welcome participants from Maryland's Garrett and Allegany Counties, and neighboring areas.

Audience: DEA Registrants, healthcare professionals, administrative and support personnel, local/state government officials, and students pursuing healthcare-related careers.

Location: PAC at Garrett College - 687 Mosser Road, McHenry, MD 21541
WebEx Webinar Platform - Simultaneous broadcast

Moderator: Justin G. Wood - Diversion Program Manager, DEA Washington Division

Virtual Registration for Saturday, March 16, 2024: WebEx Webinars (capacity is limited to the first 500 attendees)

In-person Registration: (capacity is limited to the first 200 attendees):
Please complete the in-person registration form (PDF)

Registration is required. There is no registration fee. This is a LIVE event and not recorded. The program is informational and not for credit.

Any questions regarding this event may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email at: WashingtonDiversionOutreach@dea.gov


Save the Date

What: DEA's 2nd Annual Supply Chain Conference

Purpose: The conference provides a venue in which representatives from the supply chain industry, their affiliated associations, and DEA can engage in discussions concerning existing federal regulations, issues requiring regulatory changes, clarification of DEA policy, and the development of initiatives to reduce diversion of pharmaceutical controlled substances while ensuring an adequate and uninterrupted supply.

Who: DEA registered manufacturers, distributors, pharmacists, importers, and exporters.

When: April 30 - May 2, 2024

Where: Little Rock, Arkansas [A virtual component will be offered for those who are unable to attend in person.]

Topics: DEA is soliciting relevant topics of discussion from registrants. Please email your suggestions to ODLL@dea.gov no later than Friday, February 16th.

Break Out Sessions: Registrants interested in participating in a breakout session to discuss Quota or Import/Export issues with DEA staff are requested to submit a request to ODLL@dea.gov no later than Friday, April 5th.

Please note: There is no fee to attend this conference. To ensure in-person participation is available to all interested registrants DEA is requesting that no more than 3 persons per DEA registration number plan to attend in-person. Additional participants are welcome to attend virtually. Participants not registering in advance will not be permitted to attend the conference. In the past, there was confusion as to whether private practice attorneys or consulting firms may or may not attend DEA-sponsored conferences for industry. If these individuals or firms represent registrants or their affiliated associations on an "as-needed basis", DEA does not view them as employees of a registrant or an association, but as paid consultants. As such, they are not eligible to attend these types of conferences.

More information will be forthcoming as details are finalized.